| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 406,893 | 405,066 | 421,815 | 436,890 | | Cost of Revenue | 134,685 | 143,294 | 128,062 | 131,669 | | | Gross Profit | 272,208 | 261,772 | 293,753 | 305,221 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,199 | 9,679 | 5,841 | 8,879 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 83,595 | 85,167 | 104,288 | 92,031 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 180,414 | 166,926 | 183,624 | 204,311 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 33,205 | (27,897) | (19,411) | (52,673) | | Earnings Before Interest And Taxes | 221,017 | 161,840 | (131,772) | 147,345 | | Interest Expense | 7,288 | 8,128 | 8,757 | 9,099 | | Income Before Tax | 213,729 | 153,712 | (140,529) | 138,246 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
| (10,344) | (10,611) | | | | Net Income From Continuing Ops | 213,729 | 153,712 | 151,824 | 138,246 | | | Non-recurring Events | | Discontinued Operations | (8,342) | (283) | (134) | (915) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 205,387 | 153,429 | 151,690 | 137,331 | | Preferred Stock And Other Adjustments | (6,215) | 63,573 | 197,067 | (197,067) | | | Net Income Applicable To Common Shares | $199,172 | $217,002 | $348,757 | ($59,736) |
|
0.20% Nasdaq 
0.14%
Income Statement
